Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 2,018 | 4,867 | 3,243 | 2,403 | 2,255 |
| Operating Income | -2,018 | -4,867 | -3,243 | -2,403 | -2,255 |
| Interest Expense | 4 | 5 | 3 | 784 | 34 |
| Other Income | 0 | 450 | 0 | 143 | -134 |
| Pre-tax Income | -2,022 | -4,422 | -3,246 | -3,043 | -2,422 |
| Net Income Continuous | -2,022 | -4,422 | -3,246 | -3,043 | -2,422 |
| Net Income | $-2,022 | $-4,422 | $-3,246 | $-3,043 | $-2,422 |
| EPS Basic Total Ops | -4.75 | -11.00 | -9.50 | -10.50 | -12.00 |
| EPS Basic Continuous Ops | -4.73 | -11.09 | -9.43 | -10.53 | -12.00 |
| EPS Diluted Total Ops | -4.75 | -11.00 | -9.50 | -10.50 | -12.00 |
| EPS Diluted Continuous Ops | -4.73 | -11.09 | -9.43 | -10.53 | -12.00 |
| EBITDA(a) | $-2,018 | $-4,866 | $-3,242 | $-2,402 | $-2,255 |